Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections among 122 Hospitals

Clinical Infectious Diseases

Volumn 61, Issue 3, 2015, Pages 361-367

  McDanel, Jennifer S ^a,b,c   Perencevich, Eli N ^a,b,c   Diekema, Daniel J ^b,d   Herwaldt, Loreen A ^a,b,d   Smith, Tara C ^a   Chrischilles, Elizabeth A ^a   Dawson, Jeffrey D ^e   Jiang, Lan ^c   Goto, Michihiko ^b,c   Schweizer, Marin L ^a,b,c  

^a Department of Epidemiology   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Iowa City Veterans Affairs Health Care System   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

beta lactams; bloodstream infection; MSSA; vancomycin

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTRIAXONE; COTRIMOXAZOLE; LINEZOLID; NAFCILLIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM;

ADULT; AGED; ANTIBIOTIC THERAPY; BLOOD CULTURE; BLOODSTREAM INFECTION; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; END STAGE RENAL DISEASE; ENDOCARDITIS; FEMALE; HUMAN; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION; MORTALITY; MULTICENTER STUDY (TOPIC); OSTEOMYELITIS; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS INFECTION; CROSS INFECTION; DRUG EFFECTS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84938605058     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ308     Document Type: Review

References (20)

1. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003; 82: 333-9.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillinresistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
3. Lam SW, Bauer SR, Neuner EA. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia. Int J Infect Dis 2012; 16:e453-6.
4. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
5. Schweizer ML, Furuno JP, Harris AD, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11:279.
6. Kim SH, Kim KH, Kim HB, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008; 52:192-7.
7. Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysisdependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44:190-6.
8. Lin MY, Weinstein RA, Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 2008; 52:3188-94.
9. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
10. Gomez J, Garcia-Vazquez E, Banos R, et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 2007; 26:239-45.
11. Kaasch AJ, Rieg S, Kuetscher J, et al. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 2013; 41:979-85.
12. Jones M, DuVall SL, Spuhl J, Samore MH, Nielson C, Rubin M. Identification of methicillin-resistant Staphylococcus aureus within the nation's Veterans Affairs medical centers using natural language processing. BMC Med Inform Decis Mak 2012; 12:34.
13. Arnold N, SohnMW, Maynard C, Hynes DM. VIReC Technical Report 2: VA-NDI Mortality Data Merge Project. VA Information Resource Center, 2006. Edward Hines, Jr. VA Hospital, Hines, I.L.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9.
15. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-36.
16. Sunenshine RH, Wright MO, Maraqakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13:97-103.
17. Harris AD, Sauberman L, Kabbash L, Greineder DK, Samore MH. Penicillin skin testing: a way to optimize antibiotic utilization. Am J Med 1999; 107:166-8.
18. Perencevich EN, Weller PF, Samore MH, Harris AD. Benefits of negative penicillin skin test results persist during subsequent hospital admissions. Clin Infect Dis 2001; 32:317-9.
19. Psaty BM, Siscovick DS. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA 2010; 304:897-8.
20. Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999; 149:981-3.